Cost-effectiveness analysis of toripalimab plus bevacizumab as first-line therapy for advanced hepatocellular carcinoma.

Checking your browser before accessing pmc.ncbi.nlm.nih.gov ... Click here if you are not automatically redirected after 5 seconds.

Related documents

• On dedicated institutions and funding to support disaster risk reduction: Reflections on local instrumentation in Chile.#659900
• Self management strategies for hypertensive patients on treatment in selected clinics at Ga-Dikgale, Capricorn District, Limpopo, South Africa.#659901
• From integration to use: a qualitative study of barriers and facilitators to postpartum family planning use in northeast Ethiopia—a multistakeholder perspective.#659902
• Universal Health Coverage in Pakistan: Challenges, Reforms, and the Road to 2030.#659903
• Association of social restrictions with fear of cancer recurrence in hematopoietic stem cell transplantation patients: an exploratory analysis of the potential chain mediation role of illness perception and cognitive emotion regulation.#659904